Showing results (211-220 of 216) with videos related to
Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 216 results.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 12, 2023
A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistanceSubhayan Das, Moumita Kundu, Atif Hassan, et al.Cancer Letters|December 28, 2016
Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapyRashmi Bharti, Goutam Dey, Indranil Banerjee, et al.International Journal of Cancer|February 26, 2016
Abrus agglutinin is a potent anti-proliferative and anti-angiogenic agent in human breast cancerSujit K Bhutia, Birendra Behera, Durgesh Nandini Das, et al.Journal of Materials Chemistry. B|April 9, 2020
Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapyB N Prashanth Kumar, Nagaprasad Puvvada, Shashi Rajput, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancerBradley A Schiff, Andrea B McMurphy, Samar A Jasser, et al.Oncogene|May 11, 2018
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivoAditya Parekh, Subhayan Das, Sheetal Parida, et al.Pageof 22